Literature DB >> 26307634

Incomplete penetrance of CD46 mutation causing familial atypical hemolytic uremic syndrome.

Divya Bhatia1, Priyanka Khandelwal1, Aditi Sinha1, Pankaj Hari1, Hae Il Cheong2,3,4, Arvind Bagga5.   

Abstract

BACKGROUND: Hemolytic uremic syndrome (HUS) secondary to homozygous mutations in CD46 is uncommon. While heterozygous individuals may remain asymptomatic, homozygous mutations with severely depleted CD46 surface expression without disease manifestation is rare.
METHODS: We report on two siblings with features suggestive of hemolytic uremic syndrome. Estimation of CD46 expression by flow cytometry and gene sequencing were performed in members of this family.
RESULTS: Three siblings, two of whom were symptomatic, had markedly decreased (<10%) cell surface expression of CD46 and homozygous splice site mutation (IVS2 + 2 T > G) in the CD46 gene; the other 10-year-old sibling was asymptomatic. The illness was preceded by dengue shock syndrome in the index case. Both parents and two other siblings were heterozygous for this CD46 mutation.
CONCLUSIONS: Homozygous IVS2 + 2 T > G mutation in CD46 gene, similar to heterozygous mutation, may be clinically silent at least during childhood. The role of antecedent infections in triggering the disease requires further examination.

Entities:  

Keywords:  Atypical hemolytic uremic syndrome; Dengue; Membrane cofactor protein

Mesh:

Substances:

Year:  2015        PMID: 26307634     DOI: 10.1007/s00467-015-3189-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  20 in total

1.  Dengue fever-induced hemolytic uremic syndrome.

Authors:  Willem Joost Wiersinga; Cornelis G Scheepstra; Jocelyn S Kasanardjo; Peter J de Vries; Hans Zaaijer; Suzanne E Geerlings
Journal:  Clin Infect Dis       Date:  2006-09-15       Impact factor: 9.079

2.  Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.

Authors:  Marina Noris; Jessica Caprioli; Elena Bresin; Chiara Mossali; Gaia Pianetti; Sara Gamba; Erica Daina; Chiara Fenili; Federica Castelletti; Annalisa Sorosina; Rossella Piras; Roberta Donadelli; Ramona Maranta; Irene van der Meer; Edward M Conway; Peter F Zipfel; Timothy H Goodship; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 8.237

Review 3.  Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.

Authors:  Anna Richards; M Kathryn Liszewski; David Kavanagh; Celia J Fang; Elizabeth Moulton; Veronique Fremeaux-Bacchi; Giuseppe Remuzzi; Marina Noris; Timothy H J Goodship; John P Atkinson
Journal:  Mol Immunol       Date:  2006-08-01       Impact factor: 4.407

4.  Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.

Authors:  Tara K Maga; Carla J Nishimura; Amy E Weaver; Kathy L Frees; Richard J H Smith
Journal:  Hum Mutat       Date:  2010-06       Impact factor: 4.878

5.  Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome.

Authors:  Maren Sullivan; Zoran Erlic; Michael M Hoffmann; Klaus Arbeiter; Ludwig Patzer; Klemens Budde; Bernd Hoppe; Martin Zeier; Karl Lhotta; Lisa A Rybicki; Andreas Bock; Gani Berisha; Hartmut P H Neumann
Journal:  Ann Hum Genet       Date:  2010-01       Impact factor: 1.670

6.  Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.

Authors:  Iain Moore; Lisa Strain; Isabel Pappworth; David Kavanagh; Paul N Barlow; Andrew P Herbert; Christoph Q Schmidt; Scott J Staniforth; Lucy V Holmes; Roy Ward; Lynn Morgan; Timothy H J Goodship; Kevin J Marchbank
Journal:  Blood       Date:  2009-10-27       Impact factor: 22.113

7.  Recurrence of HUS due to CD46/MCP mutation after renal transplantation: a role for endothelial microchimerism.

Authors:  V Frémeaux-Bacchi; N Arzouk; S Ferlicot; B Charpentier; R Snanoudj; A Dürrbach
Journal:  Am J Transplant       Date:  2007-08       Impact factor: 8.086

8.  The CD46-Jagged1 interaction is critical for human TH1 immunity.

Authors:  Gaëlle Le Friec; Devon Sheppard; Pat Whiteman; Christian M Karsten; Salley Al-Tilib Shamoun; Adam Laing; Laurence Bugeon; Margaret J Dallman; Teresa Melchionna; Chandramouli Chillakuri; Richard A Smith; Christian Drouet; Lionel Couzi; Veronique Fremeaux-Bacchi; Jörg Köhl; Simon N Waddington; James M McDonnell; Alastair Baker; Penny A Handford; Susan M Lea; Claudia Kemper
Journal:  Nat Immunol       Date:  2012-10-21       Impact factor: 25.606

Review 9.  Atypical hemolytic uremic syndrome.

Authors:  David Kavanagh; Tim H Goodship; Anna Richards
Journal:  Semin Nephrol       Date:  2013-11       Impact factor: 5.299

10.  Atypical haemolytic uraemic syndrome associated with a CD46 mutation triggered by Shigella flexneri.

Authors:  Vicky Brocklebank; Edwin K S Wong; Rick Fielding; Timothy H J Goodship; David Kavanagh
Journal:  Clin Kidney J       Date:  2014-04-11
View more
  2 in total

1.  Hemolytic uremic syndrome in a developing country: Consensus guidelines.

Authors:  Arvind Bagga; Priyanka Khandelwal; Kirtisudha Mishra; Ranjeet Thergaonkar; Anil Vasudevan; Jyoti Sharma; Saroj Kumar Patnaik; Aditi Sinha; Sidharth Sethi; Pankaj Hari; Marie-Agnes Dragon-Durey
Journal:  Pediatr Nephrol       Date:  2019-04-15       Impact factor: 3.714

2.  Mutations in membrane cofactor protein (CD46) gene in Indian children with hemolytic uremic syndrome.

Authors:  Priyanka Khandelwal; Shweta Birla; Divya Bhatia; Mamta Puraswani; Himanshi Saini; Aditi Sinha; Pankaj Hari; Arundhati Sharma; Arvind Bagga
Journal:  Clin Kidney J       Date:  2017-08-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.